MRNA Moderna, Inc.

NEUTRAL Impact: 2/10 Insider Cluster (2 insiders)
Horizon immediate Filed May 22, 2026 Processed 18d 7h ago
Insider cluster: 2 insiders, $3.0M total
Latest settled — T+5d
MRNA ▼ -2.96% at T+5d
NEUTRAL call ✗ call lost -2.96% · α vs SPY -4.17% · entry $46.99 → $45.60
Next anchor: T+20d in 13d
Last close $47.60 (close Jun 8) · +1.30% from $46.99 entry
Entry anchored
May 22, 2026
via day open
T+1d
+1.04%
call +1.04% · α +1.03%
$47.48
settled 15d ago
T+5d
-2.96%
call -2.96% · α -4.17%
$45.60
settled 9d ago
T+20d
call — · α —
in 13d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Two Moderna insiders sold a total of $3.02M in open-market sales over a 7-day window. Director Noubar Afeyan exercised and sold 9,263 shares for $434K, while President Stephen Hoge sold 53,300 shares for $2.58M. The total sales represent ~0.016% of Moderna's $18.8B market cap, a trivial amount that does not signal material insider concern.

Key Financial Metrics

Direction
selling
Total Value
$3.0M
Insiders
2

Actionable Insight

Insider sales are trivial relative to market cap and likely driven by routine diversification or tax planning. Hoge's sale may be tied to a 10b5-1 plan given the single large block. No bearish signal — ignore for trading purposes.

Key Facts

  • Two insiders sold a combined $3.02M in open-market sales over 7 days
  • President Stephen Hoge sold 53,300 shares at $48.40 for $2.58M on 2026-05-15
  • Director Noubar Afeyan sold 9,263 shares at $46.84 for $434K on 2026-05-21
  • Total sales represent ~0.016% of Moderna's $18.8B market cap
  • Afeyan's sale followed derivative exercises at $0 and $19.15 per share (non-cash acquisition)
  • No insider purchases were reported in the cluster

Financial Impact

Total insider sales of $3.02M, representing 0.016% of market cap

insider holdings

Risk Factors

  • Insider sales could increase if stock rallies further, but current level is immaterial
  • No insider buying to offset the selling pattern

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
30% bullish (30 analysts)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-MRNA-1779490839769
9 reports for MRNA
Performance horizon
100% Hit rate 3 of 3 directional calls best @ T+60▲ +14.15%Mar 5, 2026
Filters
Rows
Reports for MRNA — sortable, filterable
Type Now
May 31, 2026
9d ago
ANALYST-UPGRADE
BULLISH ★ 1/10
$39.50 $43.64▲ +10.48%▲ +8.89%$47.60 (+20.50%)
May 22, 2026
18d ago
Insider Cluster
NEUTRAL ★ 2/10
$46.99 $45.60▼ −2.96%▼ −4.17%$47.60 (+1.30%)
May 21, 2026
19d ago
144
NEUTRAL ★ 2/10
$47.19 $47.05▼ −0.30%▼ −2.15%$47.60 (+0.87%)
May 8, 2026
4w ago
144
NEUTRAL ★ 2/10
$54.31 $50.03▼ −7.88%▼ −9.35%$47.60 (−12.36%)
May 1, 2026
5w ago
ANALYST-UPGRADE
NEUTRAL ★ 1/10
$39.50 $43.64▲ +10.48%▲ +8.89%$47.60 (+20.50%)
Mar 30, 2026
10w ago
Court Ruling
NEUTRAL ★ 3/10
$48.16 $49.94▲ +3.70%▼ −0.60%$47.60 (−1.17%)
Mar 16, 2026
12w ago
DEFA14A
NEUTRAL ★ 3/10
$53.82 $51.28▼ −4.72%▼ −2.06%$47.60 (−11.56%)
Mar 5, 2026
13w ago
8-K
BEARISH ★ 8/10
$53.65 $53.20▲ +0.84%▼ −1.40%$47.60 (+11.28%)
Feb 28, 2026
14w ago
Institutional Cluster
BULLISH ★ 7/10
$52.82 $55.73▲ +5.51%▲ +6.72%$47.60 (−9.88%)
Showing 9 of 9

US Market Status

Market Closed — Opens in 7h

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access